Abstract
Purpose
To compare the Y type (side-by-side) and T type (stent-in-stent) bilateral biliary metal stenting in malignant hilar obstruction in terms of treatment outcomes, including post-stenting serum bilirubin level and stent patency.
Materials and Methods
41 consecutive patients with advanced hilar malignancies who underwent percutaneous placement of bilateral metallic stents - Y (n = 23) and T types (n = 18) - were retrospectively reviewed. We evaluated stent patency after the procedure by cholangiogram and abdominal CT. Pre- and post-stenting serum bilirubin level (total, direct bilirubin) at 1 week and at 1 month were compared. Student t-test and Kaplan-Meier method were used in the statistical analysis.
Results
After comparing the median stent patency according to both types, they did not differ significantly (Y: 38 days, T: 61 days; p = 0.141). There was a more decrease in the total and direct bilirubin of the T type compared to the Y type after 1 week (p = 0.013, 0.025). However, no significant difference existed between the decreasing bilirubin rates of both types after 1 month (p = 0.923, 0.742).
References
1. Han YM, Kwak HS, Jin GY, Lee SO, Chung GH. Treatment of malignant biliary obstruction with a PTFE-covered self-expandable nitinol stent. Korean J Radiol. 2007. 8:410–417.
2. Kim KR, Kim JH, Park WK, Jang JC, Cho JH, Kim TN, et al. The effect of percutaneous bilateral metalic stent for hilar cholangiocarcinoma. Yeungnam Univ J Med. 2005. 22:211–220.
3. Inal M, Akgül E, Aksungur E, Seydaoğlu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol. 2003. 14:1409–1416.
4. Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc. 2002. 56:835–841.
5. Laméris JS, Stoker J, Nijs HG, Zonderland HM, Terpstra OT, van Blankenstein M, et al. Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology. 1991. 179:703–707.
6. Lee BH, Choe DH, Lee JH, Kim KH, Chin SY. Metallic stents in malignant biliary obstruction: prospective long-term clinical results. AJR Am J Roentgenol. 1997. 168:741–745.
7. Hwang GH, You JJ, Ahn IO, Na JB, Chung SH. Management of advanced hilar biliary malignancy with X-shaped stenting technique. J Korean Radiol Soc. 2000. 42:919–924.
8. Kim YJ, Kim WH, Yang GS, Kim SW. Treatment of malignant biliar obstruction with wallstent endoprosthesis. J Korean Radiol Soc. 1995. 32:71–76.
9. Bulajic M, Panic N, Radunovic M, Scepanovic R, Perunovic R, Stevanovic P, et al. Clinical outcome in patients with hilar malignant strictures type II Bismuth-Corlette treated by minimally invasive unilateral versus bilateral endoscopic biliary drainage. Hepatobiliary Pancreat Dis Int. 2012. 11:209–214.
10. Deviere J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc. 1998. 34:95–101.
11. Jeon YS, Kim JH. T-configured dual stent placement in malignant biliary hilar obstruction: technique and clinical application. J Korean Soc Radiol. 2010. 62:211–218.
12. Kim KM, Lee KH, Chung YH, Shin JU, Lee JK, Lee KT, et al. A comparison of bilateral stenting methods for malignant hilar biliary obstruction. Hepatogastroenterology. 2012. 59:341–346.
13. Naitoh I, Hayashi K, Nakazawa T, Okumura F, Miyabe K, Shimizu S, et al. Side-by-side versus stent-in-stent deployment in bilateral endoscopic metal stenting for malignant hilar biliary obstruction. Dig Dis Sci. 2012. 57:3279–3285.
14. Hong HP, Kim SK, Seo TS. Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma. J Vasc Interv Radiol. 2008. 19:748–754.
15. Li Sol Y, Kim CW, Jeon UB, Lee NK, Kim S, Kang DH, et al. Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. AJR Am J Roentgeno. 2010. 194:261–265.
16. Stoker J, Laméris JS. Complications of percutaneously inserted biliary Wallstents. J Vasc Interv Radiol. 1993. 4:767–772.
17. Kim CW, Park AW, Won JW, Kim S, Lee JW, Lee SH. T-configured dual stent placement in malignant biliary hilar duct obstructions with a newly designed stent. J Vasc Interv Radio. 2004. 15:713–717.
18. Gwon DI, Ko GY, Yoon HK, Kim YJ, Kim TH, Lee WH, et al. Safety and efficacy of percutaneous Y-configured covered stent placement for malignant hilar biliary obstruction: a prospective, pilot study. J Vasc Interv Radiol. 2012. 23:528–534.
19. Han YM, Jin GY, Lee SO, Kwak HS, Chung GH. Flared polyurethane-covered self-expandable nitinol stent for malignant biliary obstruction. J Vasc Interv Radiol. 2003. 14:1291–1301.
20. Eum JS, Kang DH, Choi CW. A preliminary study on the usefullness of a zilver stent for bilateral stenting in patients with advanced hilar cholangiocarcinoma. Korean J Gastrointest Endosc. 2008. 36:354–360.
21. Kogure H, Isayama H, Kawakubo K, Sasaki T, Yamamoto N, Hirano K, et al. Endoscopic bilateral metallic stenting for malignant hilar obstruction using newly designed stents. J Hepatobiliary Pancreat Sci. 2011. 18:653–657.
22. Gwon DI, Ko GY, Yoon HK, Kim JH, Lee JM, Ohm JY, et al. Prospective evaluation of a newly designed T-configured stent graft system for palliative treatment of advanced hilar malignant biliary obstructions. J Vasc Interv Radiol. 2010. 21:1410–1418.
23. Lee TH, Park DH, Lee SS, Choi HJ, Lee JK, Kim TH, et al. Technical Feasibility and Revision Efficacy of the Sequential Deployment of Endoscopic Bilateral Side-by-Side Metal Stents for Malignant Hilar Biliary Strictures: A Multicenter Prospective Study. Dig Dis Sci. 2012. Epub ahead of print.